Barclays Downgrades uniQure to Equal-Weight, Lowers Price Target to $28
10/5/2026
Impact: -75
Healthcare
Barclays analyst Eliana Merle has downgraded uniQure (NASDAQ: QURE) from Overweight to Equal-Weight. The price target for the stock has been reduced significantly from $60 to $28.
AI summary, not financial advice
Share: